vaccine

In an interview with CNN’s Richard Quest, Marriott International’s newly appointed CEO Tony Capuano has emphasised the importance of a broad distribution of COVID-19 vaccines to kick-start recovery of the travel sector.

Anthony Capuano / LinkedIn

Voicing what he describes as the frustration of tourism officials around the world, the CEO maintains that “we wish we had all the tools available to solve all of these challenges ourselves. We feel that we have pulled all of the levers that we can pull, in terms of offering touchless experiences so our guests feel safe, [and] working through our loyalty program to drive demand and enthusiasm for travel.”

Ultimately, he says, “I think that broad distribution of the vaccine, [and] more open borders are going to be critical, and we only have so much influence in achieving some of those goals.”

Mr Capuano, who was recently appointed Chief Executive Officer follow the unexpected passing of Marriott President and CEO Arne Sorenson last February, continued to say that “vaccinations are the key to unlocking all the pent-up travel demand that exists – both for travellers and employees in the travel industry.”

Related

Robert Metsola: ‘If Europe wants to lead, we need to take risks’

20 March 2026
by Nicole Zammit

She believes Europe needs to take risks to deliver results and strengthen its position as a competitive economic force.

‘Money down the drain’ or ‘existential threat to Malta’? Equinox CEO unpacks EU Inc.

20 March 2026
by Nicole Zammit

Bernard Mallia warns EU Inc. could weaken Malta’s competitive edge.

Veracloud secures double win at Cybersecurity Awards 2026

20 March 2026
by MaltaCEOs

Veracloud triumphs at the Cybersecurity Awards 2026 in Greece, cementing its position as a leader in enterprise cybersecurity innovation.

Blue economy ‘central to Malta’s long-term prosperity’ – Stephanie Vella 

20 March 2026
by Nicole Zammit

An EU-backed programme is inviting Maltese blue economy startups to scale internationally through equity-free support, pilot testing and investor access.